Atypical antipsychotics for autism spectrum disorder: a network meta-analysis

This is a protocol for a new Cochrane Review (intervention).

The primary objective is to assess the comparative efficacy of atypical antipsychotics for irritability through network meta‐analysis in children and adults with autism spectrum disorder (ASD).

The secondary objective is to assess the safety and efficacy of atypical antipsychotics as medications for core and non‐core symptoms in children and adults with ASD.

Read it here on the Cochrane Library.